2017 SPEAKERS

Mr Nusrat Ali, Principal Scientist of Pharmacovigilance and Risk Management, Sunovion Pharmaceuticals Inc

Mr Nusrat Ali at World Drug Safety Americas 2017

Ms Laurie Anderson, Director - Safety Evaluation and Risk Management, GlaxoSmithKline

Ms Laurie Anderson at World Drug Safety Americas 2017

Mr Lawrence Anochie, Senior Manager of Pharmacovigilance, Arbor Pharmaceuticals Llc

Mr Lawrence Anochie at World Drug Safety Americas 2017

Nicole Baker, Director Drug Safety and EEA-QPPV, BioClinica

Dr David Balderson, Global Vice President Safety Operations, Sciformix

Dr David Balderson at World Drug Safety Americas 2017

Mr Greg Ball, Principal Statistician, Merck & Co.

Dr Khaudeja Bano, Safety Medical Director, Abbvie

Dr Khaudeja Bano at World Drug Safety Americas 2017

Mr Arvind Bellur, Director, Head of Safety Data Management, Sanofi Inc

Mr Arvind Bellur at World Drug Safety Americas 2017

Paul Beninger, Vice President Global Patient safety, Genzyme Corporation A Sanofi Co Inc

Paul Beninger at World Drug Safety Americas 2017

Andrea Best, Executive Medical Director, Pharmacovigilance and Patient Safety, AbbVie

Andrea Best at World Drug Safety Americas 2017

Dr William Bleker, Senior Director, PV & Safety Risk Management, Mirati Therapeutics, Inc.

Mariette Boerstoel-Streefland, Head Global Safety and Pharmacovigilance, Baxalta

Mariette Boerstoel-Streefland at World Drug Safety Americas 2017

Wenda Brennen, Head of Pharmacovigilance Services, PharmaLex

Wenda Brennen at World Drug Safety Americas 2017

Ms Christina Budzynski, Director, Global Integration & Delivery in Global Pharmacovigilance, Otsuka America Pharmaceutical, Inc.

Stephen Charles Schmidt, Project Manager, Aris Global

Stephen Charles Schmidt at World Drug Safety Americas 2017

Mr Shaun Comfort, Associate Director and Senior Safety Science Leader, Genentech A Member of the Roche Group

Ms Esther De La Cuesta, Global Safety Lead, Senior Medical Director Clinical Science R&D Marketed Products Group, Takeda

Cecilio Delgra, Associate Vice President Global Clinical Safety & Pharmacovigilance Head, Medical Safety Review and CT Safety Reporting, Merck

Cecilio Delgra at World Drug Safety Americas 2017

Steve Dingman, Senior Medical Director, Global Pharmacovigilance, AbbVie

Steve Dingman at World Drug Safety Americas 2017

James Duhig, Director Behavioral Sciences, AbbVie

James Duhig at World Drug Safety Americas 2017

Sarah Frise, Director Risk Management, AstraZeneca

Amrit Gill, Director-Pharmacovigilance & Risk Management, Dr Reddy's Laboratories Inc

Mr Andres Gomez, Head of Epidemiology and Signal Detection and Data Management, Bristol Myers Squibb

Mr Andres Gomez at World Drug Safety Americas 2017

Neal Grabowski, Signal Management Officer Global Patient Safety & Labeling, Amgen

Mr William W. Gregory, Senior Director , Safety & Risk Management, Pfizer

Mr William W. Gregory at World Drug Safety Americas 2017

Shahida Hasan, Associate Director-Clinical PV-NA, Dr Reddy's Laboratories

Shahida Hasan at World Drug Safety Americas 2017

Dr Philip Hewitt, Global Head of early Non Clinical Safety, Merck KGaA

Mr Frank Hong, Executive Director, Drug Safety and Epidemiology, Novartis

Mr Frank Hong at World Drug Safety Americas 2017

Dr Priya Jain, Medical Director, Alkermes

Dr Priya Jain at World Drug Safety Americas 2017

Jeremy Jokinen, Senior Director, Safety Decision Analytics, AbbVie

Jeremy Jokinen at World Drug Safety Americas 2017

Juhaeri Juhaeri, VP and Head, Global Safety Sciences, Sanofi

Juhaeri Juhaeri at World Drug Safety Americas 2017

Hyun Jung Kim, Assistant Professor, The University of Texas At Austin

Mr Robert Kane, Vice President & U.S Head, Life Science Industries, Tata Consultancy Services

Mr Neal Katz, Director of Solutions Marketing, Elsevier

Alex Kim, Safety DM, Mitsubishi Tanabe Pharma Development America

Alex Kim at World Drug Safety Americas 2017

Joash Krishna, Safety Scientist, PRA Health Sciences

Ms Eileen Leonard, Executive Director, Global Pharmacovigilance and Epidemiology, Bristol Myers Squibb

Ms Eileen Leonard at World Drug Safety Americas 2017

Dr Fabio Lievano, Vice President Safety Sciences, Medical Safety Evaluation, Abbvie Pharmaceuticals Inc

Ben locwin, President, Healthcare Science Advisors

Dr Martha Lundberg, NIH Program Director, National Institutes of Health (NIH)

Mr Michael Lusiola, Director, Patient Safety, AstraZeneca Plc

Ms Marilyn Metcalf, Senior Director of Benefit Risk Evaluation, Glaxo Smith Kline

Ms Marilyn Metcalf at World Drug Safety Americas 2017

Ms Barbara Morollo, Senior Director of Pharmacovigilance and Risk Management, bluebird bio

Ms Barbara Morollo at World Drug Safety Americas 2017

Margaret Nagle, PV Operations, Dr Reddy's Laboratories

Margaret Nagle at World Drug Safety Americas 2017

Mr William O'Brien, Chairman of Medical Surveillance Team and Virology, Global Pharmacovigilance and Epidemiology, Bristol Myers Squibb

Mr William O'Brien at World Drug Safety Americas 2017

Bruce Palsulich, Vice President of Product Strategy, Oracle Health Sciences

Bruce Palsulich at World Drug Safety Americas 2017

Ms Vaishali Patadia, Senior Director, Signal Management Group Lead, Sanofi-Aventis

Ms Vaishali Patadia at World Drug Safety Americas 2017

Urvi Patel, Pharmacy Fellow, Dr Reddy's Laboratories

Urvi Patel at World Drug Safety Americas 2017

Mansi Patel, Pharmaceutical Associate, Charotar University of Science and Technology

Mansi Patel at World Drug Safety Americas 2017

Ms Carrie Pierce, Senior Project Manager, Epidemico

Ms Carrie Pierce at World Drug Safety Americas 2017

John Price, MD Executive Director of Risk Management and GPV, Alexion Pharmaceuticals

John Price at World Drug Safety Americas 2017

Daniel Reshef, Group Medical Director, Bristol Myers Squibb

Daniel Reshef at World Drug Safety Americas 2017

Ms Theresa Robertson, Director, Pharmacovigilance Operations, Ariad Pharmaceuticals

Ms Theresa Robertson at World Drug Safety Americas 2017

Maribel Salas, Senior Principal Scientist Medical Director, Merck and Co Inc

Selena Scaglione, Senior Manager, Drug Safety & Public Health, Gilead Sciences

Sundeep Sethi, Vice President, Safety Operations, Abbvie

Neha Sheth, PhD, PharmD, Global Head, Risk Management, Astellas

Neha Sheth, PhD, PharmD at World Drug Safety Americas 2017

Barbara Silva-Tillmann, Senior Medical Director, Benefit Risk Management, Abbvie

Barbara Silva-Tillmann at World Drug Safety Americas 2017

Ms Yuliya Skorina, Associate Safety Physician, AstraZeneca

Ms Yuliya Skorina at World Drug Safety Americas 2017

Ellen Snyder, Senior Biometrician, Clinical Safety Statistics, Merck

Ellen Snyder at World Drug Safety Americas 2017

Dr John Solomon, Head of Pharmacovigilance, Sanofi-Aventis UK

Dr John Solomon at World Drug Safety Americas 2017

Dr John Solomon, Head of Pharmacovigilance, Sanofi-Aventis UK

Dr John Solomon at World Drug Safety Americas 2017

Mr Manu Sondhi, Senior Director, Novartis

Mr Manu Sondhi at World Drug Safety Americas 2017

Jeff Southwood, Director of Product Development, Adis Insight

Jeff Southwood at World Drug Safety Americas 2017

Dr Walter Straus, Executive Director and Head, Scientific Affairs/ Vaccines, Merck And Company

Dr Walter Straus at World Drug Safety Americas 2017

Ms Carmit Strauss, Risk Management, Amgen

Ms Carmit Strauss at World Drug Safety Americas 2017

Mr George Van Baelen, Head Pharmacovigilance Latin America & Caribbean, Baxalta Inc

Mr George Van Baelen at World Drug Safety Americas 2017

Mr Leonardo Viana Nicacio, Senior Global Medical Affairs Leader, AstraZeneca

Mr Leonardo Viana Nicacio at World Drug Safety Americas 2017

William Wang, Executive Director, Clinical Safety Statistics, Merck

William Wang at World Drug Safety Americas 2017

Susan Welsh, Former Chief Safety Officer, Sanofi

Susan Welsh at World Drug Safety Americas 2017

Mr Joseph Wong, Manager, Pharmacovigilance, Horizon Pharma Plc

Mr Joseph Wong at World Drug Safety Americas 2017

Sammy Yuan, Statistician, Merck

Angang Zhang, Senior Scientist, Biostatistics, Clinical Safety Statistics, Merck

Mr Xiaofeng Zhou, Senior Director, Epidemiology | Worldwide Safety and Regulatory, Pfizer, Inc

Hao Zhu, Associate Professor, Rutgers University